STOCK TITAN

Vanguard Capital Management reports 13.7M shares in Organon (OGN)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Organon & Co reported that Vanguard Capital Management beneficially owned 13,717,181 shares of Common Stock, representing 5.26% of the class as of 03/31/2026. The filing lists 1,980,163 shares as sole voting power and 13,717,181 shares as sole dispositive power. The disclosure attributes ownership to Vanguard Capital Management LLC and affiliated Vanguard entities.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports a >5% stake in Organon, showing institutional scale ownership.

The filing documents 13,717,181 shares (5.26%) beneficially owned as of 03/31/2026, with dispositive authority held by Vanguard Capital Management LLC and named affiliates. This is a standard Schedule 13G disclosure of beneficial ownership by an investment manager.

Actual voting and disposition are concentrated: 1,980,163 shares of sole voting power versus 13,717,181 shares dispositive. Subsequent filings may update holdings; timing and trading intent are not specified in this excerpt.

Beneficial ownership 13,717,181 shares as of 03/31/2026
Percent of class 5.26% beneficial ownership percentage reported
Sole voting power 1,980,163 shares shares with sole power to vote
Sole dispositive power 13,717,181 shares shares with sole power to dispose
Schedule 13G regulatory
"Name of form: SCHEDULE 13G reporting beneficial ownership"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficially owned financial
"reflects the securities beneficially owned, or deemed to be beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 13717181"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Sole voting power regulatory
"Sole power to vote or to direct the vote: 1980163"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.





68622V106

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Capital Management LLC and the following affiliates of Vanguard Capital Management LLC or business divisions of such affiliates: Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC and Vanguard Investments Australia Ltd. This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Capital Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power. This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Capital Management LLC, or business divisions of such subsidiaries, whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release.


SCHEDULE 13G



Vanguard Capital Management
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:04/30/2026

FAQ

What stake does Vanguard Capital Management report in Organon (OGN)?

Vanguard reports beneficial ownership of 13,717,181 shares (5.26%). The filing lists voting and dispositive powers and attributes ownership to Vanguard Capital Management LLC and affiliates as of 03/31/2026.

How many shares does Vanguard have voting power over in Organon?

Vanguard reports 1,980,163 shares as sole voting power. The filing states dispositive power over 13,717,181 shares, reflecting control of sale decisions by Vanguard entities.

Does the Schedule 13G name other entities tied to Vanguard's ownership?

Yes. The filing names affiliated entities including Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, and others that exercise dispositive or voting power on certain accounts.

Is Vanguard identified as owning more than 5% of Organon common stock?

Yes. The filing classifies Vanguard Capital Management as beneficial owner of 5.26% of the class, meeting the Schedule 13G threshold for disclosure.

Who signed the Schedule 13G for Vanguard Capital Management?

The filing is signed by Ashley Grim, Head of Global Fund Administration, with a signature date of 04/30/2026, certifying the reported ownership figures.